An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults
The Patient as a Driver of Change: an Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults
Sponsor: Canadian Institutes of Health Research (CIHR)
Terminated
Study funding period reached conclusion. Sample size sufficient to complete the analysis on benzodiazepines.
Other terminated trials from Canadian Institutes of Health Research (CIHR)
- Copd · Phase PHASE2/PHASE3 · Feb 2026
- Insomnia · Phase NA · Dec 2024
- X Linked Myotubular Myopathy · Phase PHASE1/PHASE2 · May 2024
- Autism Spectrum Disorder · Phase NA · May 2023
- Age-related Macular Degeneration · Phase NA · Mar 2023
See all terminations from Canadian Institutes of Health Research (CIHR)
Listed as NCT01148186, this PHASE4 trial focuses on Anxiety and Incontinence and remains terminated or withdrawn. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 9 times since 2010, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE4
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE4
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE4
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
For direct contact, visit the study record on ClinicalTrials.gov .